Publication:
Comparison of effects of sertraline and reboxetine on the loss of social functioning in major depressive disorder: A randomized, open-labeled study

dc.contributor.authorAkkaya, Cengiz
dc.contributor.authorSivrioğlu, E. Yusuf
dc.contributor.authorSarandöl, Aslı
dc.contributor.authorEker, S. Saygın
dc.contributor.authorKırlı, Selçuk
dc.contributor.buuauthorAKKAYA, CENGİZ
dc.contributor.buuauthorSİVRİOĞLU, ENVER YUSUF
dc.contributor.buuauthorSARANDÖL, ASLI
dc.contributor.buuauthorEKER, SALİH SAYGIN
dc.contributor.buuauthorKIRLI, SELÇUK
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Psikiyatri Anabilim Dalı.
dc.contributor.researcheridQ-9477-2019
dc.contributor.researcheridEKJ-8427-2022
dc.contributor.researcheridGBQ-8020-2022
dc.contributor.researcheridFTX-6743-2022
dc.contributor.researcheridCZU-1387-2022
dc.date.accessioned2024-10-24T06:38:21Z
dc.date.available2024-10-24T06:38:21Z
dc.date.issued2006-01-01
dc.description.abstractObjective: In this study we aimed to compare the effects of sertraline and reboxetine, which are influential on two different neurotransmitters, on social functioning.Method: 41 patients conforming to the study protocol and who met DSM-IV MDD diagnostic criteria were recruited for the study. These subjects were distributed randomly into two groups, sertraline and reboxetine. The subjects were assessed six times during the study which lasted 11 weeks. At each assessment the subjects were asked to complete "Hamilton Depression Rating Scale" (HDRS), "Montgomery-Asberg Depression Rating Scale" (MADRS) and "Social Adaptation Self-evaluation Scale (SASS).Results: In both groups, the decrease in HDRS and MADRS scores was found to be statistically significant starting from the 2nd visit, compared to the values prior to medication. The decrease in SASS scores, on the other hand, was significant starting from the 3rd visit. In comparison of reboxetine and sertraline groups, HDRS scores were found to be significantly higher in the reboxetine group in visits 2, 3, and 4. However, no significant difference was found in MADRS and SASS scores.Discussion and Conclusion: In this study two antidepressants which create a selective effect via serotonin and noradrenalin were compared and it was found that clinically an earlier response and remission was provided with reboxetine. Nevertheless, it is notable that there was no statistically significant difference on their social functioning levels.
dc.identifier.endpage13
dc.identifier.issn1018-8681
dc.identifier.issue1
dc.identifier.startpage5
dc.identifier.urihttps://hdl.handle.net/11452/46992
dc.identifier.volume19
dc.identifier.wos000421396900001
dc.indexed.wosWOS.ESCI
dc.language.isoen
dc.publisherKare Yayınevi
dc.relation.journalDüşünen Adam-Journal of Psychiatry and Neurological Sciences
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectDepression
dc.subjectSocial functioning
dc.subjectRemission
dc.subjectSass
dc.subjectPsychiatry
dc.titleComparison of effects of sertraline and reboxetine on the loss of social functioning in major depressive disorder: A randomized, open-labeled study
dc.typeArticle
dspace.entity.typePublication
relation.isAuthorOfPublication2cf95da9-e4e6-49cd-8e6d-4035e13c8446
relation.isAuthorOfPublicationd25787a6-1805-4701-9525-0f4353379be4
relation.isAuthorOfPublication7153f5e1-2cc6-4e30-9214-f5e5b6f51b44
relation.isAuthorOfPublication993acecf-7d9d-4016-ba83-92e52b487719
relation.isAuthorOfPublicationd1ab1da7-b6f7-4246-93a5-2d26aef85c46
relation.isAuthorOfPublication.latestForDiscovery2cf95da9-e4e6-49cd-8e6d-4035e13c8446

Files

Collections